Manesh Raman Patel, MD

Professor of Medicine
Chief, Division of Cardiology
Chief, Division of Clinical Pharmacology
Member in the Duke Clinical Research Institute
Campus mail 2301 Erwin Road, Hafs Building, Room 8695, Durham, NC 27710
Phone (919) 681-4441
Email address manesh.patel@duke.edu

Manesh Patel is the Chief of the Division of Cardiology and the Division of Clinical Pharmacology.  His clinical interests include diagnostic and interventional coronary angiography, peripheral angiography and endovascular intervention.  His is involved in several clinical trials involving patients with cardiovascular disease and in cardiac imaging.  He is also the Chair of the American College of Cardiology Task Force for Appropriate Use Criteria for Cardiovascular Procedures and is Chair of the American Heart Association Diagnostic and Interventional Cath Committee.

Patel's interest in cardiac imaging, quality of care, cardiac devices is also evident in his research.  His integration of these efforts into his roles at Duke was recognized in 2010 when he received the prestigious Duke Cardiology Fellowship Mentor Award.   In 2011, Dr. Patel was named the endowed John Bush Simpson Assistant Professor of Cardiology.  In 2013, Dr. Patel received the Robert M. Califf Faculty clinical research Award.

Currently, Dr. Patel is leading an effort to redesign the delivery of care to patients undergoing invasive catheterization procedures in the health system with a specific aim of measure and providing individualized, patient centered, innovative, and efficient care.

In Their Words

Education and Training

  • Fellow In Cardiology, Medicine, Duke University, 2002 - 2006
  • Fellow In Cardiology, Medicine, Duke University, 2000 - 2001
  • Medical Resident, Medicine, Duke University, 1997 - 2000
  • M.D., Emory University, 1997

Publications

Vemulapalli, S, Hellkamp, AS, Jones, WS, Piccini, JP, Mahaffey, KW, Becker, RC, Hankey, GJ, Berkowitz, SD, Nessel, CC, Breithardt, G, Singer, DE, Fox, KAA, and Patel, MR. "Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial." American heart journal 178 (August 2016): 74-84.

PMID
27502854
Full Text

Douglas, PS, De Bruyne, B, Pontone, G, Patel, MR, Norgaard, BL, Byrne, RA, Curzen, N, Purcell, I, Gutberlet, M, Rioufol, G, Hink, U, Schuchlenz, HW, Feuchtner, G, Gilard, M, Andreini, D, Jensen, JM, Hadamitzky, M, Chiswell, K, Cyr, D, Wilk, A, Wang, F, Rogers, C, Hlatky, MA, and PLATFORM Investigators, . "1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease: The PLATFORM Study." Journal of the American College of Cardiology 68, no. 5 (August 2016): 435-445.

PMID
27470449
Full Text

Patel, MR, Hellkamp, AS, Fox, KAA, ROCKET AF Executive Committee, Steering Committee, and and Investigators, . "Point-of-Care Warfarin Monitoring in the ROCKET AF Trial." The New England journal of medicine 375, no. 4 (July 6, 2016): 390-391.

PMID
27433844
Full Text

Breithardt, G, Baumgartner, H, Berkowitz, SD, Hellkamp, AS, Piccini, JP, Lokhnygina, Y, Halperin, JL, Singer, DE, Hankey, GJ, Hacke, W, Becker, RC, Nessel, CC, Mahaffey, KW, Califf, RM, Fox, KAA, Patel, MR, and ROCKET AF Steering Committee & Investigators, . "Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban." Heart (British Cardiac Society) 102, no. 13 (July 2016): 1036-1043.

PMID
26888572
Full Text

Nguyen, E, White, CM, Patel, MR, Fields, LE, Peacock, WF, Crivera, C, and Coleman, CI. "Doses of apixaban and rivaroxaban prescribed in real-world United States cardiology practices compared to registration trials." Current medical research and opinion 32, no. 7 (July 2016): 1277-1279.

PMID
27009372
Full Text

Ortiz, A, Abiose, A, Bichet, DG, Cabrera, G, Charrow, J, Germain, DP, Hopkin, RJ, Jovanovic, A, Linhart, A, Maruti, SS, Mauer, M, Oliveira, JP, Patel, MR, Politei, J, Waldek, S, Wanner, C, Yoo, H-W, and Warnock, DG. "Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry." Journal of medical genetics 53, no. 7 (July 2016): 495-502.

PMID
26993266
Full Text

Mark, DB, Federspiel, JJ, Cowper, PA, Anstrom, KJ, Hoffmann, U, Patel, MR, Davidson-Ray, L, Daniels, MR, Cooper, LS, Knight, JD, Lee, KL, Douglas, PS, and PROMISE Investigators, . "Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease." Annals of internal medicine 165, no. 2 (July 2016): 94-102.

PMID
27214597
Full Text

Fordyce, CB, Hellkamp, AS, Lokhnygina, Y, Lindner, SM, Piccini, JP, Becker, RC, Berkowitz, SD, Breithardt, G, Fox, KAA, Mahaffey, KW, Nessel, CC, Singer, DE, Patel, MR, and ROCKET AF Steering Committee and Investigators, . "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF." Circulation 134, no. 1 (July 2016): 37-47.

PMID
27358435
Full Text

Piccini, JP, Hellkamp, AS, Washam, JB, Becker, RC, Breithardt, G, Berkowitz, SD, Halperin, JL, Hankey, GJ, Hacke, W, Mahaffey, KW, Nessel, CC, Singer, DE, Fox, KAA, and Patel, MR. "Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation"." Circulation 134, no. 2 (July 2016): e7-e8. (Letter)

PMID
27400902
Full Text

Dalton, JE, Zidar, DA, Udeh, BL, Patel, MR, Schold, JD, and Dawson, NV. "Practice Variation Among Hospitals in Revascularization Therapy and Its Association With Procedure-related Mortality." Medical care 54, no. 6 (June 2016): 623-631.

PMID
27050445
Full Text

Pages